S&P 500   3,914.46 (+2.71%)
DOW   31,667.09 (+2.38%)
QQQ   323.07 (+2.84%)
AAPL   126.99 (+4.73%)
MSFT   236.73 (+1.87%)
FB   265.52 (+3.07%)
GOOGL   2,070.64 (+2.41%)
TSLA   711.78 (+5.37%)
AMZN   3,134.85 (+1.36%)
NVDA   548.51 (-0.01%)
BABA   241.78 (+1.69%)
CGC   34.63 (+5.74%)
GE   13.27 (+5.82%)
MU   94.39 (+3.12%)
NIO   49.90 (+9.00%)
AMD   86.06 (+1.83%)
T   28.29 (+1.43%)
F   12.01 (+2.65%)
ACB   11.14 (+5.89%)
DIS   195.84 (+3.60%)
BA   224.95 (+6.10%)
NFLX   547.72 (+1.65%)
BAC   35.99 (+3.69%)
S&P 500   3,914.46 (+2.71%)
DOW   31,667.09 (+2.38%)
QQQ   323.07 (+2.84%)
AAPL   126.99 (+4.73%)
MSFT   236.73 (+1.87%)
FB   265.52 (+3.07%)
GOOGL   2,070.64 (+2.41%)
TSLA   711.78 (+5.37%)
AMZN   3,134.85 (+1.36%)
NVDA   548.51 (-0.01%)
BABA   241.78 (+1.69%)
CGC   34.63 (+5.74%)
GE   13.27 (+5.82%)
MU   94.39 (+3.12%)
NIO   49.90 (+9.00%)
AMD   86.06 (+1.83%)
T   28.29 (+1.43%)
F   12.01 (+2.65%)
ACB   11.14 (+5.89%)
DIS   195.84 (+3.60%)
BA   224.95 (+6.10%)
NFLX   547.72 (+1.65%)
BAC   35.99 (+3.69%)
S&P 500   3,914.46 (+2.71%)
DOW   31,667.09 (+2.38%)
QQQ   323.07 (+2.84%)
AAPL   126.99 (+4.73%)
MSFT   236.73 (+1.87%)
FB   265.52 (+3.07%)
GOOGL   2,070.64 (+2.41%)
TSLA   711.78 (+5.37%)
AMZN   3,134.85 (+1.36%)
NVDA   548.51 (-0.01%)
BABA   241.78 (+1.69%)
CGC   34.63 (+5.74%)
GE   13.27 (+5.82%)
MU   94.39 (+3.12%)
NIO   49.90 (+9.00%)
AMD   86.06 (+1.83%)
T   28.29 (+1.43%)
F   12.01 (+2.65%)
ACB   11.14 (+5.89%)
DIS   195.84 (+3.60%)
BA   224.95 (+6.10%)
NFLX   547.72 (+1.65%)
BAC   35.99 (+3.69%)
S&P 500   3,914.46 (+2.71%)
DOW   31,667.09 (+2.38%)
QQQ   323.07 (+2.84%)
AAPL   126.99 (+4.73%)
MSFT   236.73 (+1.87%)
FB   265.52 (+3.07%)
GOOGL   2,070.64 (+2.41%)
TSLA   711.78 (+5.37%)
AMZN   3,134.85 (+1.36%)
NVDA   548.51 (-0.01%)
BABA   241.78 (+1.69%)
CGC   34.63 (+5.74%)
GE   13.27 (+5.82%)
MU   94.39 (+3.12%)
NIO   49.90 (+9.00%)
AMD   86.06 (+1.83%)
T   28.29 (+1.43%)
F   12.01 (+2.65%)
ACB   11.14 (+5.89%)
DIS   195.84 (+3.60%)
BA   224.95 (+6.10%)
NFLX   547.72 (+1.65%)
BAC   35.99 (+3.69%)
Log in
NASDAQ:ALGN

Align Technology Stock Forecast, Price & News

$564.82
-2.29 (-0.40 %)
(As of 03/1/2021 02:38 PM ET)
Add
Compare
Today's Range
$559.56
Now: $564.82
$577.15
50-Day Range
$509.64
MA: $571.71
$620.45
52-Week Range
$127.88
Now: $564.82
$634.46
Volume31,664 shs
Average Volume561,682 shs
Market Capitalization$44.54 billion
P/E Ratio25.70
Dividend YieldN/A
Beta1.68
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Moderate, Lite and Express packages, and Invisalign Go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company sells its products in the United States, the Netherlands, China, and internationally. Align Technology, Inc. was founded in 1997 and is headquartered in Tempe, Arizona.
Align Technology logo

Headlines

Align Stock Surges on Earnings… Again
February 4, 2021 |  marketbeat.com
Align Technology: A Stock to Sink Your Teeth Into
February 16, 2021 |  stocknews.com
Orthofix (OFIX) Launches Limb Lengthening System in US & UK
February 12, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ALGN
CUSIP01625510
Phone408-470-1000
Employees14,530
Year Founded1997

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.41 billion
Cash Flow$6.19 per share
Book Value$17.08 per share

Profitability

Net Income$442.78 million

Miscellaneous

Market Cap$44.54 billion
Next Earnings Date5/5/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.98 out of 5 stars

Medical Sector

65th out of 1,965 stocks

Surgical Appliances & Supplies Industry

5th out of 40 stocks

Analyst Opinion: 2.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -
$564.82
-2.29 (-0.40 %)
(As of 03/1/2021 02:38 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALGN News and Ratings via Email

Sign-up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Align Technology (NASDAQ:ALGN) Frequently Asked Questions

Is Align Technology a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Align Technology stock.
View analyst ratings for Align Technology
or view top-rated stocks.

What stocks does MarketBeat like better than Align Technology?

Wall Street analysts have given Align Technology a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Align Technology wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Align Technology's next earnings date?

Align Technology is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Align Technology
.

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) announced its earnings results on Tuesday, February, 2nd. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.47. The medical equipment provider had revenue of $834.50 million for the quarter, compared to analysts' expectations of $793.56 million. Align Technology had a net margin of 76.00% and a trailing twelve-month return on equity of 68.99%. Align Technology's quarterly revenue was up 28.4% on a year-over-year basis. During the same quarter last year, the company earned $1.53 EPS.
View Align Technology's earnings history
.

How has Align Technology's stock been impacted by Coronavirus (COVID-19)?

Align Technology's stock was trading at $202.18 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ALGN stock has increased by 179.4% and is now trading at $564.82.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for ALGN?

14 brokerages have issued 12 month price targets for Align Technology's stock. Their forecasts range from $165.00 to $680.00. On average, they expect Align Technology's share price to reach $475.46 in the next twelve months. This suggests that the stock has a possible downside of 15.8%.
View analysts' price targets for Align Technology
or view top-rated stocks among Wall Street analysts.

Who are Align Technology's key executives?

Align Technology's management team includes the following people:
  • Mr. Joseph M. Hogan, Pres, CEO & Director (Age 64)
  • Mr. John F. Morici, CFO & Sr. VP of Global Fin. (Age 54) (LinkedIn Profile)
  • Mr. Emory M. Wright, Sr. VP of Global Operations (Age 51, Pay $1.09M) (LinkedIn Profile)
  • Mr. Vamsi Mohan-Raj Pudipeddi, Sr. VP and Chief Product, Innovation & Marketing Officer (Age 49, Pay $1.13M) (LinkedIn Profile)
  • Ms. Julie Tay, Sr. VP & MD of Asia Pacific (Age 54, Pay $1.21M) (LinkedIn Profile)
  • Mr. Zelko Relic, Sr. VP & Chief Technology Officer (Age 56) (LinkedIn Profile)
  • Ms. Shirley Stacy, VP of Corp. Communications & Investor Relations
  • Ms. Julie Ann Coletti, Sr. VP and Chief Legal & Regulatory Officer (LinkedIn Profile)
  • Mr. Stuart Hockridge, Sr. VP of Global HR (Age 49) (LinkedIn Profile)
  • Mr. Simon Beard, MD for Americas Region & Sr. VP (Age 54)

What is Joe Hogan's approval rating as Align Technology's CEO?

346 employees have rated Align Technology CEO Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among Align Technology's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Align Technology's key competitors?

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), salesforce.com (CRM), Mastercard (MA) and Tesla (TSLA).

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Who are Align Technology's major shareholders?

Align Technology's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.89%), Edgewood Management LLC (5.85%), Sands Capital Management LLC (3.74%), Alliancebernstein L.P. (2.37%), Price T Rowe Associates Inc. MD (1.98%) and Janus Henderson Group PLC (1.73%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Emory Wright, George J Morrow, Greg J Santora, John Morici, Joseph Lacob, Joseph M Hogan, Julie Ann Coletti, Julie Tay, Raphael Pascaud, Simon Beard, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler, Yuval Shaked and Zelko Relic.
View institutional ownership trends for Align Technology
.

Which major investors are selling Align Technology stock?

ALGN stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Edgewood Management LLC, Hillhouse Capital Advisors LTD., Bank of New York Mellon Corp, Sands Capital Management LLC, Alliancebernstein L.P., Alyeska Investment Group L.P., and Alyeska Investment Group L.P.. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, Emory Wright, George J Morrow, John Morici, Joseph Lacob, Joseph M Hogan, Julie Ann Coletti, Julie Tay, Simon Beard, Stuart A Hockridge, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler, Yuval Shaked, and Zelko Relic.
View insider buying and selling activity for Align Technology
or view top insider-selling stocks.

Which major investors are buying Align Technology stock?

ALGN stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Winslow Capital Management LLC, Nuveen Asset Management LLC, Lord Abbett & CO. LLC, Veritas Investment Partners UK Ltd., Voloridge Investment Management LLC, Frontier Capital Management Co. LLC, and Strs Ohio. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan, and Vamsi Mohan Raj Pudipeddi.
View insider buying and selling activity for Align Technology
or or view top insider-buying stocks.

How do I buy shares of Align Technology?

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Align Technology's stock price today?

One share of ALGN stock can currently be purchased for approximately $564.82.

How much money does Align Technology make?

Align Technology has a market capitalization of $44.54 billion and generates $2.41 billion in revenue each year. The medical equipment provider earns $442.78 million in net income (profit) each year or $4.96 on an earnings per share basis.

How many employees does Align Technology have?

Align Technology employs 14,530 workers across the globe.

When was Align Technology founded?

Align Technology was founded in 1997.

What is Align Technology's official website?

The official website for Align Technology is www.aligntech.com.

Where are Align Technology's headquarters?

Align Technology is headquartered at 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134.

How can I contact Align Technology?

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.